TipRanks
Go Ultimate55% OFF

Modern Healthcare Technology Holdings Limited (M3L) AI Stock Analysis

DE:M3L

Modern Healthcare Technology Holdings Limited

(Frankfurt:M3L)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Cash generationConsistent positive operating cash flow and free cash flow across FY2023–FY2026 indicate the company generates cash despite accounting losses. Durable cash conversion reduces dependence on external financing, funds operations and investment, and supports deleveraging and strategic flexibility over the medium term.
Negative Factors
Persistent net losses & negative ROEMulti-year net losses and a negative return on equity signal the business has not produced shareholder returns. Persistent losses erode capital efficiency, constrain reinvestment, increase financing costs, and make it harder to justify the equity base unless profitability turns sustainably positive.

Modern Healthcare Technology Holdings Limited (M3L) vs. iShares MSCI Germany ETF (EWG)

Not enough price history over this period.

Market Cap
EUR 7.72M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-37.5
Beta (1Y)
8.80
Revenue Growth
-9.65%
EPS Growth
66.67%
Country
Germany
Employees
783
Sector
Consumer Cyclical
Sector Strength
61
Industry
Personal Products & Services

Modern Healthcare Technology Holdings Limited Business Overview & Revenue Model

Company Description

Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, Mainland China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Skinca...

Modern Healthcare Technology Holdings Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:M3L against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:1830HK:183068NeutralHKD 1.43B8.0143.78%12.76%-14.68%-13.60%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
HK:1448HK:144856NeutralHKD 6.03B14.006.50%20.98%――
HK:8483HK:848355NeutralHKD 248.00M-24.54-77.06%―-38.43%-394.12%
HK:2521HK:252152NeutralHKD 1.80B49.266.47%―2.78%-41.23%
HK:8296HK:829647NeutralHKD 17.95M-0.76-17.95%―-26.00%-188.55%

* Consumer Cyclical Sector Average

Performance Comparison

0%100%200%HK:1448HK:1830HK:8296HK:8483HK:2521Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:M3L and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:M3LModern Healthcare Technology Holdings Limited―――
HK:1448Fu Shou Yuan International Group 2.64-0.25-8.69%
HK:1830Perfect Medical Health Management Limited1.14-0.08-6.79%
HK:8296Sino-Life Group Limited0.19-0.19-50.00%
HK:8483Max Sight Group Holdings Limited0.310.22248.31%
HK:2521Shenghui Cleanness Group Holdings Limited0.930.53131.25%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.